IQVIA Holdings Inc. reported a notable increase in financial performance for the second quarter and first half of 2026, with revenues reaching $4.368 billion for the three months ending June 30, 2026, an increase of 8.7% from $4.017 billion in the same period of 2025. For the first six months of 2026, revenues totaled $8.519 billion, up 8.6% from $7.846 billion year-over-year. The growth was driven by increases in both the Commercial Solutions and Research & Development Solutions segments, with the latter contributing significantly to the overall revenue increase.
The company's cost of revenues, excluding depreciation and amortization, also rose, amounting to $2.933 billion in the second quarter of 2026, compared to $2.694 billion in the prior year, reflecting a 8.9% increase. For the first half of 2026, costs reached $5.729 billion, a 9.6% rise from $5.225 billion. This increase was attributed to higher compensation and reimbursed expenses necessary to support revenue growth. Despite these rising costs, IQVIA's net income attributable to the company was $256 million for the second quarter, slightly down from $266 million in 2025, while net income for the first half was $530 million, compared to $515 million in the previous year.
Strategically, IQVIA has undergone organizational changes, consolidating its reportable segments from three to two: Commercial Solutions and Research & Development Solutions. This restructuring aims to align with industry evolution and improve operational efficiency. The company also engaged in several acquisitions during the first half of 2026, contributing to a total goodwill of $16.604 billion as of June 30, 2026. The company’s employee headcount remains approximately 94,000, reflecting its extensive operational footprint across more than 100 countries.
Operationally, IQVIA reported a backlog of $34.2 billion in contracted services as of June 30, 2026, with expectations to convert approximately $9.2 billion of this backlog into revenue within the next twelve months. The company’s cash and cash equivalents stood at $1.909 billion, a decrease from $1.980 billion at the end of 2025, while total debt was reported at $16.081 billion. The company continues to maintain a robust liquidity position, supported by cash flows from operations and available credit facilities.
Looking ahead, IQVIA anticipates continued revenue growth driven by its strategic focus on enhancing service offerings and expanding its market presence. The company remains committed to leveraging its data analytics capabilities and technological advancements to meet the evolving needs of its clients in the life sciences and healthcare sectors.
About IQVIA HOLDINGS INC.
IQVIA is a global provider of healthcare data, analytics, and technology solutions serving the life sciences and healthcare industries. It offers clinical research services, real-world evidence, commercial insights, and AI-powered platforms to optimize drug development, clinical trials, and healthcare operations. With extensive proprietary data and a broad client base, IQVIA supports innovation, regulatory compliance, and improved patient outcomes worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov